Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kazdal

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Pathology. Clinical Research|January 12, 2023
First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinomaOlaf Neumann, Ulrich Lehmann, Stephan Bartels, et al.
Frontiers in Oncology|July 16, 2021
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung CancerLea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, et al.
The Journal of Pathology. Clinical Research|January 29, 2024
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitorsMichael Menzel, Martina Kirchner, Klaus Kluck, et al.
Lung Cancer (Amsterdam, Netherlands)|August 16, 2023
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implicationsHuriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, et al.
Pulmonary Circulation|June 9, 2023
Is iron deficiency caused by Vivienne Theobald, Ekkehard Grünig, Nicola Benjamin, et al.
Pathologie (Heidelberg, Germany)|August 4, 2022
[Structure and content of the EU-IVDR : Current status and implications for pathology]Andy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Frontiers in Oncology|November 17, 2022
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitorsHannah Schindler, Fabienne Lusky, Lea Daniello, et al.
Pathologie (Heidelberg, Germany)|February 3, 2023
Structure and content of the EU-IVDR : Current status and implications for pathologyAndy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 24, 2025
Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor OriginsMichael Allgäuer, Klaus Kluck, Petros Christopoulos, et al.
Cancers|September 8, 2019
RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer SamplesMartina Kirchner, Olaf Neumann, Anna-Lena Volckmar, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Pathology. Clinical Research|January 12, 2023
First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinomaOlaf Neumann, Ulrich Lehmann, Stephan Bartels, et al.
Frontiers in Oncology|July 16, 2021
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung CancerLea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, et al.
The Journal of Pathology. Clinical Research|January 29, 2024
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitorsMichael Menzel, Martina Kirchner, Klaus Kluck, et al.
Lung Cancer (Amsterdam, Netherlands)|August 16, 2023
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implicationsHuriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, et al.
Pulmonary Circulation|June 9, 2023
Is iron deficiency caused by Vivienne Theobald, Ekkehard Grünig, Nicola Benjamin, et al.
Pathologie (Heidelberg, Germany)|August 4, 2022
[Structure and content of the EU-IVDR : Current status and implications for pathology]Andy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Frontiers in Oncology|November 17, 2022
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitorsHannah Schindler, Fabienne Lusky, Lea Daniello, et al.
Pathologie (Heidelberg, Germany)|February 3, 2023
Structure and content of the EU-IVDR : Current status and implications for pathologyAndy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 24, 2025
Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor OriginsMichael Allgäuer, Klaus Kluck, Petros Christopoulos, et al.
Cancers|September 8, 2019
RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer SamplesMartina Kirchner, Olaf Neumann, Anna-Lena Volckmar, et al.
Pageof 12